979 results on '"Chapman, Kenneth R."'
Search Results
2. The Effect of Simulated Obstructive Apneas on Mechanical Characteristics of Lower Airways in Individuals with Asthma
3. Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses
4. Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation
5. Unraveling the link between PTBP1 and severe asthma through machine learning and association rule mining method
6. Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study
7. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
8. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
9. Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study
10. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study
11. Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study
12. Impaired Sleep Quality in COPD Is Associated With Exacerbations The CanCOLD Cohort Study
13. Patients' and physicians’ perspectives on the burden and management of asthma: Results from the APPaRENT 2 study
14. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
15. Asthma patients' and physicians’ perspectives on the burden and management of asthma
16. Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial
17. Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
18. Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
19. Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma
20. Normative Reference Equations for Breathlessness Intensity during Incremental Cardiopulmonary Cycle Exercise Testing
21. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
22. Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review
23. Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics
24. Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers
25. Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study
26. Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study
27. Triple inhaled therapy for asthma in Canada
28. Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
29. A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada.
30. Improving the Management of COPD in Women
31. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
32. Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma
33. The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations?
34. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease
35. Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review
36. Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma
37. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
38. Assessing biomarkers in a real-world severe asthma study (ARIETTA)
39. Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma
40. Physical Activity and Symptom Burden in COPD: The Canadian Obstructive Lung Disease Study
41. Factors Associated with Attrition in a Longitudinal Cohort of Older Adults in the Community
42. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
43. The prevalence of asthma and atopy in schoolchildren from Porto Alegre, Brazil, has plateaued
44. The effect of exacerbations on lung density in alpha-1 antitrypsin deficiency
45. Triple Therapy of Asthma—Permutations and Combinations
46. Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?
47. Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency
48. Burdens, hurdles, and limitations: a comprehensive discussion of the evolution facing renewable energy development in Virginia
49. Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study
50. Association of Obstructive Apnea with Thoracic Fluid Shift and Small Airways Narrowing in Asthma During Sleep
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.